CONSOLIDATED BALANCE SHEETS - USD ($) shares in Thousands, $ in Millions	Sep. 30, 2023	Sep. 24, 2022
Current assets:
Cash and cash equivalents	$ 29,965	$ 23,646
Marketable securities	31,590	24,658
Accounts receivable, net	29,508	28,184
Vendor non-trade receivables	31,477	32,748
Inventories	6,331	4,946
Other current assets	14,695	21,223
Total current assets	143,566	135,405
Non-current assets:
Marketable securities	100,544	120,805
Property, plant and equipment, net	43,715	42,117
Other non-current assets	64,758	54,428
Total non-current assets	209,017	217,350
Total assets	352,583	352,755
Current liabilities:
Accounts payable	62,611	64,115
Other current liabilities	58,829	60,845
Deferred revenue	8,061	7,912
Commercial paper	5,985	9,982
Term debt	9,822	11,128
Total current liabilities	145,308	153,982
Non-current liabilities:
Term debt	95,281	98,959
Other non-current liabilities	49,848	49,142
Total non-current liabilities	145,129	148,101
Total liabilities	290,437	302,083
Commitments and contingencies
Common stock, shares outstanding (in shares)	15,550,061	15,943,425
Common stock, shares issued (in shares)	15,550,061	15,943,425
Shareholders’ equity:
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,550,061 and 15,943,425 shares issued and outstanding, respectively	$ 73,812	$ 64,849
Accumulated deficit	(214)	(3,068)
Accumulated other comprehensive loss	(11,452)	(11,109)
Total shareholders’ equity	62,146	50,672
Total liabilities and shareholders’ equity	$ 352,583	$ 352,755